Navigation Links
Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
Date:10/23/2007

ecific long-lasting response against cancer. In clinical studies, patients typically received three infusions over a one-month period as a complete course of therapy.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of
'/>"/>

SOURCE Dendreon Corporation
Copyright©2007 PR Newswire.
All rights reserved

7

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of Data at American Urological Association Annual Meeting
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
8. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
9. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
10. Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
11. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164299/Surgical-I...cal incision closures market holds enormous signif... being performed each year. Surgical disciplines s...
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNew...unced the completion of a Phase I study of CPSI-23... the production of TNF-alpha and other pro-inflamm...bility dose escalation study in healthy volunteers...inical testing. ,, All 30 enrolled subjects c...
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Med...shed ultrasound solutions, will showcase leading u...p, GE Logiq I and Siemens X300 Premium Edition dur...ety of North America (RSNA) conference, being held...sin-based MedPro Imaging markets ultrasound produc...
Breaking Medicine Technology:Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Common mental disorders may be more common than we think 56851 1Common mental disorders may be more common than we think 56851 2Oil and wildlife dont mix in Ecuadors Eden 9876 1Oil and wildlife dont mix in Ecuadors Eden 9876 2Oil and wildlife dont mix in Ecuadors Eden 9876 3ADA FDI World Dental Federation Observe World Oral Health Day 56846 1ADA FDI World Dental Federation Observe World Oral Health Day 56846 2
...foromist(TM) (Formoterol Fumarate) Inhalation ...ence --, NAPA, Calif., May 20 Data presented tod... Thoracic Society (ATS) demonstrate,that concomita...n,(formoterol fumarate inhalation solution; FFIS),...ium; TIO) is significantly more effective than,tre...
...th HALO device leads to 100% patient response ...if., May 20 BARRX Medical, Inc., a global,technol...announced the,publication of two related European ...rly esophageal cancer and pre-cancerous dysplasia ...erapy with the HALO ablation,system. Barrett,s eso...
Other Medicine Technology:Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3
(Date:11/30/2009)...K, Nov. 30 Reportlinker.com announ... in its catalogue: ,, Gene Therapy - Worldwide...p://www.reportlinker.com/p0164218/Gene-Therapy---W..., Gene therapy promises to be one of the most i...icant achievements for curing disease have been ac...
(Date:11/30/2009)...ess may help delay progression and reduce expenses...ealthDay News) -- Medical care for osteoarthritis ... a year, according to a new study. , Of that am...ay $36.1 billion in out-of-pocket costs. Annual in...36 per male patient. Women also have higher out-of...
(Date:11/30/2009)...enate bills stack up , , MONDAY, Nov. 30...oving through the U.S. Congress differ in a number...uction in the number of uninsured Americans. , ...es earlier this month would expand coverage to 96 ...ebate a proposal to expand coverage to 94 percent ...
(Date:11/30/2009)...ShowMyPC has released an online service that lets ...ere. This is the first hosted service in the world... program. Result, blazing fast performance even ov...Santa Clara, CA (PRWEB) November 30, 2009 -- ShowM...ccess Service that uses the familiar Microsoft Rem...
(Date:11/30/2009)...According to Steven McConnell, DDS, teaching your ...son is a good idea, but brushing their teeth corre...g down with a virus. , (P...rnia Dental Hygienists’ Association, it is c...health and flu prevention because the H1N1 virus s...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 2Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 3Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 4
.... 9 Almost Family, Inc. (Nasdaq: AFAM ), a le...vices, announced today that Steve Guenthner, Senio...cheduled to present at the 27th Annual J.P. Morgan... Date: Wednesday, January 14, 2009, ...
...Buttery Christmas cookies, eggnog, juicy beef roas.... Happy holiday food unfortunately can send blood ...rsity scientists now offer a promising new weapon ...disease that often results. , The researchers suc...
...vailable in French . , Scientists from McGill ...UHC) and the Douglas Mental Health University Inst...Discoveries of 2008 for their groundbreaking work....ne, Psychiatry; McGill Earth and Planetary Science...
...age of 300 calories every day, study finds, , ... like many Americans, soda and coffee drinks have ...ings from a new study may make you drop that super...drinking almost 50 additional calories of sweetene...
... Society of Gynecologic Oncologists (SGO) will hos...ary 5-8, 2009 at the Henry B. Gonzalez Convention ... will feature more than 360 scientific presentatio...advances for physicians and health care profession...
...9 Pierre,s Ice Cream Company, makers of,Hola Frut... another innovation,called Yovation(TM). , (Ph.../CLF014 ) , Yovation(TM) is a new premium, pr...unity of the benefits of probiotics.,Yovation(TM) ...
Other Medicine News:Health News:Synthetic HDL: A new weapon to fight cholesterol problems 2Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 2Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 3Health News:Americans Consuming More Sugary Beverages 2Health News:Americans Consuming More Sugary Beverages 3Health News:Society of Gynecologic Oncologists to Host 40th Annual Meeting on Women's Cancer 2Health News:Standing Ovation for Pierre's New Innovation! 2Health News:Standing Ovation for Pierre's New Innovation! 3
Ascent Primary Knee System - Ascent/Maxim primary interlok tibial trays
...the "Consensus Concept" approach to design by comb... experience of a Scientific Advisory Board. The re...s state-of-the-art features. Consensus Knee implan...stability and allow near normal kinematics. The co...
NexGen Complete Knee Solution Legacy Knee Posterior Stabilized (LPS)
LCS Complete Mobile-Bearing Knee System
Medicine Products: